# Quantum Financing & Acquisition

> Quantum Financing & Acquisition is a VC fund in Los Angeles backing Biotechnology and Medical. See 3 investments, check sizes, portfolio. Updated Aug 2026.

- Type: VC Fund
- Location: Los Angeles, United States
- Total investments: 3
- Last investment: Dec 2024
- Lead investor: 0%
- Last updated: Aug 2026
- Website: https://www.quantumfa.com

Quantum Financing & Acquisition is a VC fund in Los Angeles focused on Biotechnology and Medical. Quantum Advisors LLC is a fund management organization dedicated to protecting and expanding the value of community entrepreneurship. It will serve its function in a variety of ways, including but not limited to investing in venture possibilities, restructuring, expansion, and mergers and acquisitions.

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Biotechnology | 2 | 67% |
| Medical | 1 | 33% |
| Wellness | 1 | 33% |
| Therapeutics | 1 | 33% |
| Medical Device | 1 | 33% |

6 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Seed | 1 | 33% |
| Series A | 1 | 33% |
| Series C | 1 | 33% |

### Country

| Country | Investments | Share |
| --- | --- | --- |
| South Korea | 2 | 67% |
| United States | 1 | 33% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Pin Therapeutics | Pin Therapeutics is founded in Feb 2017, fast growing stage with member composition of 25% in USA and 75% in Korea. Drug discovery leaderships are from global pharma and biotech companies along with talented scientists both in Korea and USA.* Active Focus - PinE3: E3 ligase screening cascade for identifying novel warheads - PinGLUE: Assaycascade for molecular glue degrader screening* Programs - Selective Molecular Glue Degrader (CK1α) - Molecular Glue Degrader Programs (5-6 Undisclosed) - PROTAC Program (1 Undisclosed) | $13.6M | Series C | Dec 27, 2024 |  |
| PineTree Therapeutics | PineTree Therapeutics engages in the development of disruptive therapies in Oncology and Immuno-oncology. | $17M | Series A | Jul 30, 2024 |  |
| DNC Biotechnology | DNC Biotechnology is an R&D centre that researches and improves technology for medical devices. | $765.4K | Seed | Jul 03, 2023 |  |

3 of 3 investments shown.

## Co-investors
- [DSC Investment](https://shizune.co/investors/profile/dsc-investment) — VC Fund, 3 deals together
- [Atinum Partners](https://shizune.co/investors/profile/atinum-investment) — VC Fund, 1 deal together
- [Atinum Partners](https://shizune.co/investors/profile/atinum-partners) — VC Fund, 1 deal together
- [CKD Venture Capital Corporation](https://shizune.co/investors/profile/ckd-venture-capital-corporation) — VC Fund, 1 deal together
- [Future Science and Technology Holdings](https://shizune.co/investors/profile/future-science-and-technology-holdings) — VC Fund, 1 deal together
- [Hallym University](https://shizune.co/investors/profile/hallym-university) — VC Fund, 1 deal together

## Similar investors

### Similar industry
- [Innova Memphis](https://shizune.co/investors/profile/innova-memphis) — VC Fund
- [SOSV](https://shizune.co/investors/profile/sosv) — VC Fund
- [Enterprise Ireland](https://shizune.co/investors/profile/enterprise-ireland) — VC Fund

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund

### Similar country
- [Strong Ventures](https://shizune.co/investors/profile/strong-ventures) — VC Fund
- [Korea Credit Guarantee Fund](https://shizune.co/investors/profile/korea-credit-guarantee-fund) — VC Fund
- [Kakao Ventures](https://shizune.co/investors/profile/kakao-ventures) — VC Fund

## Featured in investor lists
- [Medical Device Investors in South Korea](https://shizune.co/investors/medical-device-investors-south-korea)
- [Medical Device VC Funds in South Korea](https://shizune.co/investors/medical-device-vc-funds-south-korea)

## FAQ

### What does Quantum Financing & Acquisition invest in?

Quantum Financing & Acquisition invests primarily in Biotechnology, Medical and Wellness startups, most often at Seed and Series A stage. Most of the 3 investments tracked by Shizune back companies in South Korea. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did Quantum Financing & Acquisition last invest?

The most recent investment recorded for Quantum Financing & Acquisition closed in Dec 2024. Shizune tracks 3 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co